Rectosigmoid resection at the time of primary cytoreduction for advanced ovarian cancer. A multi-center analysis of surgical and oncological outcomes

Gynecologic Oncology

Volumn 126, Issue 2, 2012, Pages 220-223

  Peiretti, Michele ^a   Bristow, Robert E ^b   Zapardiel, Ignacio ^c   Gerardi, Melissa ^d   Zanagnolo, Vanna ^a   Biffi, Roberto ^a   Landoni, Fabio ^a   Bocciolone, Luca ^a   Aletti, Giovanni Damiano ^a   Maggioni, Angelo ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^d DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Bowel resection; Cytoreduction; Ovarian cancer

Indexed keywords

ANTINEOPLASTIC METAL COMPLEX; CARBOPLATIN; DOXORUBICIN; GEMCITABINE; PACLITAXEL; TOPOTECAN;

ADULT; ADVANCED CANCER; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; CANCER SURVIVAL; COLORECTOSTOMY; COLOSTOMY; CYTOREDUCTIVE SURGERY; DEEP VEIN THROMBOSIS; FEMALE; FOLLOW UP; HEMOPERITONEUM; HUMAN; ILEOSTOMY; INTESTINE SURGERY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MULTIPLE CYCLE TREATMENT; OVARY CANCER; OVERALL SURVIVAL; PELVIS ABSCESS; PERITONEUM CANCER; PLEURA EFFUSION; POSTOPERATIVE ILEUS; PRIORITY JOURNAL; PYELONEPHRITIS; RECTOSIGMOID SURGERY; RETROSPECTIVE STUDY; SURGICAL INFECTION; URINARY TRACT INFECTION;

ADULT; AGED; AGED, 80 AND OVER; COLECTOMY; FEMALE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; RECTUM; RETROSPECTIVE STUDIES; SIGMOID DISEASES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84862902262     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.04.030     Document Type: Article

References (25)

1. National Cancer Institute [home page on the internet]. Available from: www. cancer.gov/cancertopics/types/ovarian.
2. Chi DS, Eisenhauer EL, Lang J, Huh J, Haddad L, Abu-Rustum NR, et al. What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? Gynecol Oncol 2006;103(2):559-64. (Pubitemid 44602167)
3. Shih KK, Chi DS. Maximal cytoreductive effort in epithelial ovarian cancer surgery. J Gynecol Oncol 2010;21(2):75-80.
4. Zapardiel I, Morrow CP. New terminology for cytoreduction in advanced ovarian cancer. Lancet Oncol 2011;12(3):214.
5. Peiretti M, Zanagnolo V, Aletti GD, Bocciolone L, Colombo N, Landoni F, et al. Role of maximal primary cytoreductive surgery in patients with advanced epithelial ovarian and tubal cancer: surgical and oncological outcomes. Single institution experience. Gynecol Oncol Nov 2010;119(2):259-64.
6. Eisenkop SM, Spirtos NM. Procedures required to accomplish complete cytoreduction of ovarian cancer: is there a correlation with "biological aggressiveness"and survival? Gynecol Oncol 2001;82:435-41. (Pubitemid 32826441)
7. Barber HRK, Brunschwig A. Pelvic exenteration for locally advanced and recurrent ovarian cancer. Surgery 1965;58:935-7.
8. Hudson CN. A radical operation for fixed ovarian tumors. J Obstet Gynaecol Br Commonw 1968;75:1155-60.
9. Hudson CN, Chir M. Surgical treatment of ovarian cancer. Gynecol Oncol 1973;1:370-8.
10. Clayton RD, Obemair A, Hammond IG, Leung YC, McCartney AJ. The western Australian experience of the use of en bloc resection of ovarian cancer with concomitant rectosigmoid colectomy. Gynecol Oncol 2002;84:53-7. (Pubitemid 34056466)
11. Berek JS, Hacker NF, Lagasse LD. Rectosigmoid colectomy and reanastomosis to facilitate resection of primary and recurrent gynecologic cancer. Obstet Gynecol 1984;64:715-20. (Pubitemid 15205482)
12. Soper JT, Couchman G, Berchuk A, Clarke-Pearson D. The role of partial sigmoid colectomy for debulking epithelial ovarian carcinoma. Gynecol Oncol 1991;41: 239-44.
13. Obermair A, Hagenauer S, Tamandl D, Clayton RD, Nicklin JL, Perrin LC, et al. Safety and efficacy of low anterior en bloc resection as part of cytoreductive surgery for patients with ovarian cancer. Gynecol Oncol 2001;83:115-20. (Pubitemid 32959887)
14. Sainz de la Cuesta R, Goodman A, Halverson SS, Fuller AF. En bloc pelvic peritoneal resection of the intraperitoneal pelvic viscera in patients with advanced epithelial ovarian cancer. Cancer J Sci Am 1996;2:152-7.
15. Hacker NF, Berek JS, Lagasse LD, Nieberg RK, Elashoff RM. Primary cytoreductive surgery for epithelial ovarian cancer. Obstet Gynecol 1983;61(4):413-20. (Pubitemid 13158699)
16. Hoskins WJ. Epithelial ovarian carcinoma: principles of primary surgery. Gynecol Oncol 1994;55(3 Pt 2):S91-6.
17. Cheung HY, Chung CC, Tsang WW, Wong JC, Yau KK, Li MK. Endolaparoscopic approach vs conventional open surgery in the treatment of obstructing left-sided colon cancer: a randomized controlled trial. Arch Surg 2009;144(12):1127-32.
18. Bristow RE, Puri I, Chi DS. Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis. Gynecol Oncol 2009;112:265-74.
19. Richardson DL, Mariani A, Cliby WA. Risk factors for anastomotic leak after recto-sigmoid resection for ovarian cancer. Gynecol Oncol 2006;103:667-72. (Pubitemid 44604496)
20. Mourton SM, Temple LK, Abu-Rustum NR, Gemignani ML, Sonoda Y, Bochner BH, et al. Morbidity of rectosigmoid resection and primary anastomosis in patients undergoing primary cytoreductive surgery for advanced epithelial ovarian cancer. Gynecol Oncol 2005;99(3):608-14. (Pubitemid 41686544)
21. Cai HB, Zhou YF, Chen HZ, Hou HY. The role of bowel surgery with cytoreduction for epithelial ovarian cancer. Clin Oncol 2007;19:757-62.
22. Spirtos NM, Eisenkop SM, Schlaerthm JB, Ballon SC. Second-look laparotomy after modified posterior exenteration: patterns of persistence and recurrence in patients with stage III and stage IV ovarian cancer. Am J Obstet Gynecol 2000;182(6):1321-7. (Pubitemid 30437396)
23. Hertel H, Diebolder H, Herrmann J, Köhler C, Kühne-Heid R, Possover M, et al. Is the decision for colorectal resection justified by histopathologic findings: a prospective study of 100 patients with advanced ovarian cancer. Gynecol Oncol 2001;83(3):481-4. (Pubitemid 33139707)
24. Aletti GD, Podratz KC, Jones MB, Cliby WA. Role of rectosigmoidectomy and stripping of pelvic peritoneum in outcomes of patients with advanced ovarian cancer. J Am Coll Surg 2006;203(4):521-6. (Pubitemid 44416260)
25. Salani R, Zahurak ML, Santillan A, Giuntoli RL, Bristow RE. Survival impact of multiple bowel resections in patients undergoing primary cytoreductive surgery for advanced ovarian cancer: a case-control study. Gynecol Oncol 2007;107:495-9. (Pubitemid 350160861)